XML 30 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Operating activities      
Net loss $ (45,290) $ (31,390) $ (20,610)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 1,465 691 584
Stock-based compensation expense 4,168 1,653 578
Noncash interest expense 354 112 44
Change in fair value of warrants   1 530
Loss on disposal of asset     6
Deferred rent (119) 5 (5)
Changes in operating assets and liabilities:      
Accounts receivable (168) (201)  
Prepaid expenses and other assets 190 (1,217) (138)
Inventory (568) (115)  
Accounts payable 177 (208) 372
Accrued expenses and other liabilities 260 2,405 586
Deferred revenue 2,066 80  
Net cash used in operating activities (37,465) (28,184) (18,053)
Investing activities      
Purchases of property and equipment (7,974) (2,084) (513)
Decrease in restricted cash 80   80
Net cash used in investing activities (7,894) (2,084) (433)
Financing activities      
Proceeds from issuance of common stock in public offering, net of offering costs 33,677 58,089  
Proceeds from issuance of redeemable convertible preferred stock, net     39,768
Proceeds from issuance of common stock and stock options exercises, net 1,804 153 55
Proceeds from issuance of note payable, net 10,000 19,714  
Repayments of notes payable (309) (4,037) (848)
Net cash provided by financing activities 45,172 73,919 38,975
Net (decrease) increase in cash and cash equivalents (187) 43,651 20,489
Cash and cash equivalents at beginning of period 73,849 30,198 9,709
Cash and cash equivalents at end of period 73,662 73,849 30,198
Supplemental disclosures of cash flow information      
Cash paid for interest 1,506 515 345
Supplemental disclosures of noncash investing and financing activities      
Accrued property and equipment 247 128  
Leasehold improvements paid by landlord 1,268 121  
Public offering costs unpaid at year end $ 420    
Accretion of Series A-1, A-2, B, C, D and E redeemable convertible preferred stock to redemption value   4,570 $ 6,908
Conversion of redeemable and convertible preferred stock to common stock   117,383  
Conversion of preferred warrants to common stock   $ 1,226